Events

International B2B Software Days 2021
MAY
Mon
10
MAY
Tue
11
MAY
Wed
12

This was 4 years ago

Location

Online

Programmes
ICT SME Instrument Security EIC Pilot

This year, the 6th edition of the International B2B Software Days (in former years organised in Vienna) is again packed with lots of interesting inspiration, information and learning opportunities.

Participation if free of charge. More than 2000 participants are expected, and even though a virtual event, networking is still possible as you can request personal online B2B meetings with each of them.

The events highlights at a glance:

  • Fascinating Keynotes from Ericsson, SAAB, LinkedIn, Amazon, IEEE, City of Vienna and more
  • Outstanding Thematic Workshops: 5G, Cybersecurity, AI and Ethics, Data visualisation, Finding developers, Software Patenting, UX, SaaS Export and more
  • Pitch your start-up idea in front of > 50 international investors
  • Promote your business offers and requests through our marketplace
  • Find the needle in the haystack: book online 20' B2B meetings with your next business partner
  • Contribute to Corporate challenges through our Co-Creation Labs
  • Team-up with our Partner Country this year: Sweden

 

More detailed information and registration at the event website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.